Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ikeda, Takaya
86  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Pharmacokinetic and dose‐finding study of osimertinib in pa..:

Fujiwara, Yutaka ; Makihara, Reiko ; Hase, Tetsunari...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154887/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Phase II study of IRInotecan treatment after COmbined chemo..:

Tomono, Hiromi ; Taniguchi, Hirokazu ; Fukuda, Minoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542459/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Immune complexome analysis of serum samples from non-small-..:

Aizawa Rika ; Nakamura Yoichi ; Ikeda Takaya...
10.1016/j.cca.2022.05.021.  , 2022
Link: http://hdl.handle.net/10..
 
?
4

Phase I study of amrubicin plus cisplatin and concurrent ac..:

Akagi, Kazumasa ; Taniguchi, Hirokazu ; Fukuda, Minoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376170/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

The CLIP1-LTK fusion is an oncogenic driver in non-small ce..:

Izumi, Hiroki ; Matsumoto, Shingo ; Liu, Jie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687755/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Impact of concomitant medication on clinical outcomes in pa..:

Miura, Kaho ; Sano, Yoshiyuki ; Niho, Seiji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258365/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Amrubicin in previously treated patients with malignant ple..:

Ikeda, Takaya ; Takemoto, Shinnosuke ; Senju, Hiroaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327919/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
8

Phase II trial of a non‐platinum triplet for patients with ..:

Takemoto, Shinnosuke ; Nakamura, Yoichi ; Gyoutoku, Hiroshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397920/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
9

Randomized phase II study of pemetrexed or pemetrexed plus ..:

Fukuda Minoru ; Kitazaki Takeshi ; Ogawara Daiki...
10.1016/j.lungcan.2019.01.008.  , 2019
Link: http://hdl.handle.net/10..
 
?
10

Phase II study of ramucirumab and docetaxel for previously ..:

Takemoto, Shinnosuke ; Fukuda, Minoru ; Yamaguchi, Hiroyuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996979/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
11

Adverse renal effects of anaplastic lymphoma kinase inhibit..:

Shimada, Midori ; Fukuda, Minoru ; Fukuda, Masaaki...
info:eu-repo/semantics/altIdentifier/doi/10.2147/OTT.S136837.  , 2017
Link: https://www.dovepress.co..
 
?
12

Alert Regarding Cisplatin-induced Severe Adverse Events in ..:

Sumiyoshi, Makoto ; Soda, Hiroshi ; Sadanaga, Noriaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465418/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

Adverse renal effects of anaplastic lymphoma kinase inhibit..:

Shimada, Midori ; Fukuda, Minoru ; Fukuda, Masaaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499859/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
14

Phase I study of pemetrexed and concurrent radiotherapy for..:

Takemoto, Shinnosuke ; Nakamura, Yoichi ; Fukuda, Minoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668476/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

Adverse renal effects of anaplastic lymphoma kinase inhibit..:

Shimada Midori ; Fukuda Minoru ; Fukuda Masaaki...
10.2147/OTT.S136837.  , 2017
Link: http://hdl.handle.net/10..
 
1-15